Brad Shumel

Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

Andrew Blauvelt, Marjolein de Bruin‐Weller, Melinda Gooderham et al. · The Lancet · 2017 · 1.2K citations · Full text

Allergy, Atopic Dermatitis, Allergy Medicine +8

Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease

Frederick E. Dewey, Viktoria Gusarova, Richard L. Dunbar et al. · New England Journal of Medicine · 2017 · 836 citations · Full text

Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t

Marjolein de Bruin‐Weller, Diamant Thaçi, Catherine Smith et al. · British Journal of Dermatology · 2017 · 468 citations · Full text

Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis

Evan S. Dellon, Marc E. Rothenberg, Margaret H. Collins et al. · New England Journal of Medicine · 2022 · 413 citations

Conjunctivitis in dupilumab clinical trials

Bolanle Akinlade, Emma Guttman‐Yassky, Marjolein de Bruin‐Weller et al. · British Journal of Dermatology · 2019 · 410 citations · Full text